This brand name is authorized in Nigeria.
The drug DORBAXIN contains one active pharmaceutical ingredient (API):
1
|
UNII
125OD7737X - METHOCARBAMOL
|
|
Methocarbamol is a centrally acting muscle relaxant. Its muscle relaxing action is the result of the inhibition of polysynaptic reflexes in the spinal marrow and subcortical centres. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-5493 | Tablet | Dorbaxin Tablet TAB 500 mg 1 x 10's (in Alu-PVC blister) | Tablet DORBAXIN TABLET METHOCARBAMOL TABLETS USP 500 MG METHOCARBAMOL USP 500MG A4-5493 Drugs MUSCULO-SKELETAL SYSTEM Imported Products 110 Prescription Only Medicine (POM) 11/12/2023 XCEL PHARMACEUTICAL LIMITED, , JONES STREET, EBUTE METTA, LAGOS 18419240 graciousdec@yahoo.co.uk STALLION LABORATORIES PVT LTD, Plot No. C1B-305, 2,3,4,&5, G.I.D.C., Kerala Ahmedabad, Gujarat State, India., India | 30/01/2025 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| M03BA03 | Methocarbamol | M Musculo-skeletal system → M03 Muscle relaxants → M03B Muscle relaxants, centrally acting agents → M03BA Carbamic acid esters |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-5493 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.